BEAT Lab receives NIH SBIR Phase I grant

BEAT Lab receives NIH SBIR Phase I grant (Sen Gupta, co-I) to study clot-targeted drug delivery using

platelet-directed liposomes. Nanomimetics Inc. (Shuwu Wang, PI) is the industry partner.